- $16.89bn
- $17.04bn
- $4.10bn
Hologic falls after 2025 profit forecast cut
Hologic Inc reports results for the quarter ended March 31 - Earnings Summary
Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty
Corrected: BRIEF-Hologic Q2 Adjusted EBITDA USD 325.8 Million Vs. IBES Estimate USD 324.7 Million
Life sciences firms jumps after Trump announces 90-day tariff pause
Life sciences firms fall as China hikes tariff on US imports
Brief: Wayde Mcmillan Elected To Hologic Board Of Directors
Tennis-Charleston Open is first clay tournament to use electronic line calling
US aid freeze sows disruption in HIV, malaria product supply chains
U.S. RESEARCH ROUNDUP-Conmed, McKesson, Veralto
Hologic cuts annual revenue forecast on weak demand for breast health products
Hologic Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Hologic Q1 Adjusted EBITDA USD 326 Million Vs. IBES Estimate USD 332 Million
Needham downgrades Hologic to 'hold' on 2025 growth hindrances
Brief: Hologic Completes Acquisition Of Gynesonics
Brief: FDA Hologic Removes Biozorb 3D Bioabsorbable Markers Due To Risk For Patient Complications
Brief: Hologic To Contribute To H5n1 Bird Flu Test Development Via Agreement Issued By CDC
Brief: Martin Madaus Elected To Hologic Board Of Directors
U.S. RESEARCH ROUNDUP-Citigroup, Salesforce, Zscaler